Consensus Paper: Radiological Biomarkers of Cerebellar Diseases

Cerebellum

Volumn 14, Issue 2, 2015, Pages 175-196

  Baldarçara, Leonardo ^a,b   Currie, Stuart ^c   Hadjivassiliou, M ^d   Hoggard, Nigel ^c   Jack, Allison ^e   Jackowski, Andrea P ^b   Mascalchi, Mario ^f,g   Parazzini, Cecilia ^h   Reetz, Kathrin ^i,j,k   Righini, Andrea ^h   Schulz, Jörg B ^i,k   Vella, Alessandra ^l   Webb, Sara Jane ^m   Habas, Christophe ⁿ  

^a UNIVERSIDADE FEDERAL DO TOCANTINS   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

^d ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF FLORENCE   (Italy)

^g CAREGGI UNIVERSITY HOSPITAL   (Italy)

^h V BUZZI CHILDREN S HOSPITAL   (Italy)

ⁱ UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^j FORSCHUNGSZENTRUM JÜLICH   (Germany)

^k Julich Aachen Research Alliance JARA   (Germany)

^l UNIVERSITY HOSPITAL OF SIENA   (Italy)

^m UNIVERSITY OF WASHINGTON   (United States)

ⁿ CENTRE HOSPITALIER NATIONAL D OPHTALMOLOGIE DES QUINZE VINGTS   (France)

more..

Author keywords

Ataxia; Autism; Cerebellum; Dementia; Diffusion; Fetal malformation; fMRI; Immunity; MRI; PET; Radiological biomarker; SPECT; Spectroscopy; Ultrasound

Indexed keywords

6 FLUORODOPA F 18; BIOLOGICAL MARKER; CYSTEINE ETHYL ESTER TC 99M; FLUORODEOXYGLUCOSE F 18; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; IOFETAMINE I 123; IOLOPRIDE I 123; [2 [[2 [[[3 (4 CHLOROPHENYL) 8 METHYL 8 AZABICYCLO[3.2.1]OCT 2 YL]METHYL](2 MERCAPTOETHYL)AMINO]ETHYL]AMINO]ETHANETHIOLATO]OXOTECHNETIUM TC 99M;

ANTIGLUTAMIC ACID DECARBOXYLASE ANTIBODY ASSOCIATED ATAXIA; ARTICLE; ATAXIA; AUTISM; AUTOSOMAL DOMINANT DISORDER; BRAIN DEVELOPMENT; BRAIN INFECTION; CEREBELLAR ATAXIA; CEREBELLUM; CEREBELLUM DISEASE; CEREBELLUM HYPOPLASIA; CEREBELLUM PONTINE HYPOPLASIA; CEREBELLUM VERMIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DEMENTIA; DEVELOPMENTAL DISORDER; FUNCTIONAL NEUROIMAGING; GLUTEN ATAXIA; HUMAN; IDIOPATHIC DISEASE; MULTIPLE SYSTEMS ATROPHY; NERVE DEGENERATION; NEUROANATOMY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PARANEOPLASTIC NEUROPATHY; POSITRON EMISSION TOMOGRAPHY; POST INFECTIOUS CEREBELLITIS; PRIMARY AUTOIMMUNE CEREBELLAR ATAXIA; PRIORITY JOURNAL; RADIODIAGNOSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SPINOCEREBELLAR DEGENERATION; VOLUMETRY; X LINKED ATAXIAS; ANIMAL; CEREBELLAR DISEASES; CONSENSUS; METABOLISM; PATHOLOGY; PROCEDURES;

ANIMALS; CEREBELLAR DISEASES; CEREBELLUM; CONSENSUS; HUMANS; NEUROIMAGING;

EID: 84925506378     PISSN: 14734222     EISSN: 14734230     Source Type: Journal    
DOI: 10.1007/s12311-014-0610-3     Document Type: Article

References (171)

1. Mascalchi M, Vella A. Magnetic resonance and nuclear medicine imaging in ataxias. Handb Clin Neurol [Rev]. 2012;103:85–110.
2. Currie S, Hadjivassiliou M, Craven IJ, Wilkinson ID, Griffiths PD, Hoggard N. Magnetic resonance imaging biomarkers in patients with progressive ataxia: current status and future direction. Cerebellum. 2013;12(2):245–66.
3. Jung BC, Choi SI, Du AX, Cuzzocreo JL, Geng ZZ, Ying HS, et al. Principal component analysis of cerebellar shape on MRI separates SCA type 2 and 6 into two archetypal modes of degeneration. Cerebellum. 2012;11:887–95.
4. Dohlinger S, Hauser TK, Borkert J, Luft AR, Schulz JB. Magnetic resonance imaging in spinocerebellar ataxias. Cerebellum [Res Support Non-US Gov’t]. 2008;7(2):204–14.
5. Luft AR, Skalej M, Welte D, Kolb R, Burk K, Schulz JB, et al. A new semiautomated, three-dimensional technique allowing precise quantification of total and regional cerebellar volume using MRI. Magn Reson Med [Clin Trial]. 1998;40(1):143–51.
6. Good C, Johnsrude I, Ashburner J, Henson R, Friston K, Frackowiak R. A voxel-based morphometric study of aging in 465 normal adult human brains. Neuroimage. 2001;14:21–36.
7. Hadjivassiliou M, Currie S, Hoggard N. MR spectroscopy in paraneoplastic cerebellar degeneration. J Neuroradiol J Neuroradiol [Lett]. 2013;40(4):310–2.
8. Currie S, Hadjivassiliou M, Craven IJ, Wilkinson ID, Griffiths PD, Hoggard N. Magnetic resonance spectroscopy of the brain. Postgrad Med J. 2013;89(1048):94–106.
9. Braga-Neto P, Dutra LA, Pedroso JL, Felício AC, Alessi H, Santos-Galduroz RF, et al. Cognitive deficits in Machado-Joseph disease correlate with hypoperfusion of visual system areas. Cerebellum. 2012;11:1037–44.
10. Nanri K, Okita M, Takeguchi M, Taguchi T, Ishiko T, Saito H, et al. Intravenous immunoglobulin therapy for autoantibody-positive cerebellar ataxia. Intern Med. 2009;48:783–90.
11. Kimura N, Kumamoto T, Masuda T, Nomura Y, Hanaoka T, Hazama Y, et al. Evaluation of the effect of thyrotropin releasing hormone (TRH) on regional cerebral blood flow in spinocerebellar degeneration using 3DSRT. J Neurol Sci. 2009;281:93–8.
12. Kimura N, Kumamoto T, Masuda T, Nomura Y, Hanaoka T, Hazama Y, et al. Evaluation of the effects of thyrotropin releasing hormone (TRH) therapy on regional cerebral blood flow in the cerebellar variant of multiple system atrophy using 3DSRT. J Neuroimaging. 2011;21:132–7.
13. Lyoo CH, Jeong Y, Ryu YH, Lee SY, Song TJ, Lee JH, et al. Effects of disease duration on the clinical features and brain glucose metabolism in patients with mixed type multiple system atrophy. Brain. 2008;131:438–46.
14. Basu S, Alavi A. Role of FDG-PET in the clinical management of paraneoplastic neurological syndrome: detection of the underlying malignancy and the brain PET-MRI correlates. Mol Imaging Biol. 2008;10:131–7.
15. Wang PS, Liu RS, Yang BH, Soong BW. Topographic brain mapping of the international cooperative ataxia rating scale. A positron emission tomography study. J Neurol. 2007;254:722–8.
16. Inagaki A, Iida A, Matsubara M, Inagaki H. Positron emission tomography and magnetic resonance imaging in spinocerebellar ataxia type 2: a study of symptomatic and asymptomatic individuals. Eur J Neurol. 2005;12:725–8.
17. Soong B, Liu R. Positron emission tomography in asymptomatic gene carriers of Machado Joseph disease. J Neurol Neurosurg Psychiatry. 1998;64:499–504.
18. Brockmann K, Reimold M, Globas C, Hauser TK, Walter U, Machulla HJ, et al. PET and MRI reveal early evidence of neurodegeneration in Spinocerebellar Ataxia Type 17. J Nucl Med. 2012;53:1074–80.
19. Hosoi Y, Suzuki-Sakao M, Terada T, Konishi T, Ouchi Y, Miyajima H, et al. GABA-A receptor impairment in cerebellar ataxia with anti-glutamic acid decarboxylase antibodies. J Neurol. 2013. doi:10.1007/s00415-013-7092-y.
20. Varrone A, Salvatore E, De Michele G, Barone P, Sansone V, Pellecchia MT, et al. Reduced striatal [123I]FP-CIT binding in SCA2 patients without parkinsonism. Ann Neurol. 2004;55:426–30.
21. Kim JM, Lee JY, Kim HJ, Kim JS, Kim YK, Park SS, et al. The wide clinical spectrum and nigrostriatal dopaminergic damage in spinocerebellar ataxia type 6. J Neurol Neurosurg Psychiatry. 2010;81:529–32.
22. Kelp A, Koeppen AH, Petrasch-Parwez E, Calaminus C, Bauer C, Portal E, et al. A novel transgenic rat model for spinocerebellar ataxia type 17 recapitulates neuropathological changes and supplies in vivo imaging biomarkers. J Neurosci. 2013;33:9068–81.
23. Malinger G, Lev D, Lerman-Sagie T. The fetal cerebellum. Pitfalls in diagnosis and management. Prenat Diagn. 2009;29:372–80.
24. Limperopoulos C, Robertson Jr RL, Khwaja OS, et al. How accurately does current fetal imaging identify posterior fossa anomalies? Am J Roentgenol. 2008;190:1637–43.
25. Garel C. Posterior fossa malformations: main features and limits in prenatal diagnosis. Pediatr Radiol. 2010;40:1038–45.
26. Parazzini C, Righini A, Rustico M, Consonni D, Triulzi F. Prenatal magnetic resonance imaging: brain normal linear biometric values below 24 gestational weeks. Neuroradiology. 2008;50:877–83.
27. Hatab MR, Kamourieh SW, Twickler DM. MR volume of the fetal cerebellum in relation to growth. J Magn Reson Imaging. 2008;27:840–5.
28. Poretti A, Limperopoulos C, Roulet-Perez E, et al. Outcome of severe unilateral cerebellar hypoplasia. Dev Med Child Neurol. 2010;52:718–24.
29. Wong AM, Bilaniuk LT, Zimmerman RA, Liu PL. Prenatal MR imaging of Dandy-Walker complex: midline sagittal area analysis. Eur J Radiol. 2012;81:26–30.
30. Tarui T, Limperopoulos C, Sullivan NR, Robertson Richard L, du Plessis AJ. Long-term developmental outcome of children with a fetal diagnosis of isolated inferior vermian hypoplasia. Arch Dis Child Fetal Neonatal. 2014;99:54–8.
31. Klockgether T, Skalej M, Wedekind D, Luft AR, Welte D, Schulz JB, et al. Autosomal dominant cerebellar ataxia type I. MRI-based volumetry of posterior fossa structures and basal ganglia in spinocerebellar ataxia types 1, 2 and 3. Brain. 1998;121(Pt 9):1687–93.
32. Schulz JB, Borkert J, Wolf S, Schmitz-Hubsch T, Rakowicz M, Mariotti C, et al. Visualization, quantification and correlation of brain atrophy with clinical symptoms in spinocerebellar ataxia types 1, 3 and 6. Neuroimage. 2010;49:158–68.
33. Jacobi H, Reetz K, du Montcel ST, Bauer P, Mariotti C, Nanetti L, et al. Biological and clinical characteristics of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 in the longitudinal RISCA study: analysis of baseline data. Lancet Neurol. 2013;12:650–8.
34. Burk K, Abele M, Fetter M, Dichgans J, Skalej M, Laccone F, et al. Autosomal dominant cerebellar ataxia type I clinical features and MRI in families with SCA1, SCA2 and SCA3. Brain. 1996;119(Pt 5):1497–505.
35. Reetz K, Costa AS, Mirzazade S, Lehmann A, Juzek A, Rakowicz M, et al. Genotype-specific patterns of atrophy progression are more sensitive than clinical decline in SCA1, SCA3 and SCA6. Brain. 2013;136:905–17.
36. Della Nave R, Ginestroni A, Tessa C, Salvatore E, De Grandis D, Plasmati R, et al. Brain white matter damage in SCA1 and SCA2. An in vivo study using voxel-based morphometry, histogram analysis of mean diffusivity and tract-based spatial statistics. Neuroimage. 2008;43:10–9.
37. Solodkin A, Peri E, Chen EE, Ben-Jacob E, Gomez CM. Loss of intrinsic organization of cerebellar networks in spinocerebellar ataxia type 1: correlates with disease severity and duration. Cerebellum. 2011;10:218–32.
38. D’Agata F, Caroppo P, Boghi A, Coriasco M, Caglio M, Baudino B, et al. Linking coordinative and executive dysfunctions to atrophy in spinocerebellar ataxia 2 patients. Brain Struct Funct. 2011;216:275–88.
39. Schols L, Kruger R, Amoiridis G, Przuntek H, Epplen JT, Riess O. Spinocerebellar ataxia type 6: genotype and phenotype in German kindreds. J Neurol Neurosurg Psychiatry. 1998;64:67–73.
40. Lukas C, Schols L, Bellenberg B, Rub U, Przuntek H, Schmid G, et al. Dissociation of grey and white matter reduction in spinocerebellar ataxia type 3 and 6: a voxel-based morphometry study. Neurosci Lett. 2006;408:230–5.
41. Alcauter S, Barrios FA, Diaz R, Fernandez-Ruiz J. Gray and white matter alterations in spinocerebellar ataxia type 7: an in vivo DTI and VBM study. Neuroimage. 2011;55:1–7.
42. Rolfs A, Koeppen AH, Bauer I, Bauer P, Buhlmann S, Topka H, et al. Clinical features and neuropathology of autosomal dominant spinocerebellar ataxia (SCA17). Ann Neurol. 2003;54:367–75.
43. Lasek K, Lencer R, Gaser C, Hagenah J, Walter U, Wolters A, et al. Morphological basis for the spectrum of clinical deficits in spinocerebellar ataxia 17 (SCA17). Brain. 2006;129:2341–52.
44. Reetz K, Kleiman A, Klein C, Lencer R, Zuehlke C, Brockmann K, et al. CAG repeats determine brain atrophy in spinocerebellar ataxia 17: a VBM study. PLoS One. 2011;6:e15125.
45. Reetz K, Lencer R, Hagenah JM, Gaser C, Tadic V, Walter U, et al. Structural changes associated with progression of motor deficits in spinocerebellar ataxia 17. Cerebellum. 2010;9:210–7.
46. Reetz K, Dogan I, Rolfs A, Binkofski F, Schulz JB, Laird AR, et al. Investigating function and connectivity of morphometric findings—exemplified on cerebellar atrophy in spinocerebellar ataxia 17 (SCA17). Neuroimage. 2012;62:1354–66.
47. Hadjivassiliou M, Grünewald RA, Chattopadhyay AK, Davies-Jones GA, Gibson A, Jarratt JA, et al. Clinical, radiological, neurophysiological, and neuropathological characteristics of gluten ataxia. Lancet. 1998;352(9140):1582–5.
48. Wilkinson ID, Hadjivassiliou M, Dickson JM, Wallis L, Grünewald RA, Coley SC, et al. Cerebellar abnormalities on proton MR spectroscopy in gluten ataxia. J Neurol Neurosurg Psychiatry. 2005;76(7):1011–3.
49. Currie S, Hoggard N, Clark MJR, Sanders DS, Wilkinson ID, Griffiths PD, et al. Alcohol induces sensitization to gluten in genetically susceptible individuals: a case control study. PLoS One. 2013;8(10):e77638. doi:10.1371/journal.pone.0077638.
50. Currie S, Hadjivassiliou M, Clark MJ, Sanders DS, Wilkinson ID, Griffiths PD, et al. Should we be ‘nervous’ about coeliac disease? Brain abnormalities in patients with coeliac disease referred for neurological opinion. J Neurol Neurosurg Psychiatry. 2012;83(12):1216–21. doi:10.1136/jnnp-2012-303281.
51. Honnorat J, Saiz A, Giometto B, Vincent A, Brieva L, de Andres C, et al. Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients. Arch Neurol. 2001;58(2):225–30.
52. Nanri K, Niwa H, Mitoma H, Takei A, Ikeda J, Harada T, et al. Low-titer anti-GAD-antibody-positive cerebellar ataxia. Cerebellum. 2013;12(2):171–5. doi:10.1007/s12311-012-0411-5.
53. Scheid R, Voltz R, Briest S, et al. Clinical insights into paraneoplastic cerebellar degeneration. J Neurol Neurosurg Psychiatry. 2006;77:529–30.
54. De Andrés C, Esquivel A, de Villoria JG, et al. Unusual magnetic resonance imaging and cerebrospinal fluid findings in paraneoplastic cerebellar degeneration: a sequential study. J Neurol Neurosurg Psychiatry. 2006;77:562–3.
55. Choi K-D, Kim JS, Park S-H, et al. Cerebellar hypermetabolism in paraneoplastic cerebellar degeneration. J Neurol Neurosurg Psychiatry. 2006;77:525–8.
56. Clapp AJ, Hunt CH, Johnson GB, Peller PJ. Semiquantitative analysis of brain metabolism in patients with paraneoplastic neurologic syndromes. Clin Nucl Med. 2013;38(4):241–7.
57. Hadjivassiliou M, Alder SJ, Van Beek EJR, Hannay MB, Lorenz E, Rao DG, et al. PET scan in clinically suspected paraneoplastic neurological syndromes: a six year prospective study in a regional neuroscience unit. Acta Neurol Scand. 2009;119:186–93.
58. Hadjivassiliou M, Boscolo S, Tongiorgi E, Grunewald RA, Sharrack B, Sanders DS, et al. Cerebellar ataxia as a possible organ specific autoimmune disease. Mov Disord. 2008;23(10):1270–377.
59. Hadjivassiliou M. Primary autoimmune cerebellar ataxia (PACA). ACNR. 2010;9(6):8–11.
60. Sunaga Y, Hikima A, Ostuka T, Morikawa A. Acute cerebellar ataxia with abnormal MRI lesions after varicella vaccination. Pediatr Neurol. 1995;13(4):340.
61. De Bruecker Y, Claus F, Demaerel P, Ballaux F, Sciot R, Lagae L, et al. MRI findings in acute cerebellitis. Eur Radiol. 2004;14(8):1478.
62. Daaboul Y, Vern BA, Blend MJ. Brain SPECT imaging and treatment with IVIg in acute post-infectious cerebellar ataxia: case report. Neurol Res. 1998;20(1):85.
63. Nagamitsu S, Matsuishi T, Ishibashi M, Yamashita Y, Nishimi T, Ichikawa K, et al. Decreased cerebellar blood flow in postinfectious acute cerebellar ataxia. J Neurol Neurosurg Psychiatry. 1999;67(1):109.
64. Rapoport M, Reekum R, Mayberg H. The role of the cerebellum in cognition and behavior: a selective review. J Neuropsychiatry Clin Neurosci. 2000;12(2):193–8.
65. Baldaçara L, Borgio JGF, Moraes WAS, Lacerda ALT, Montaño MBMM, Tufik S, et al. Cerebellar volume in patients with dementia. Rev Bras Psiquiatr. 2011;33(2):122–9.
66. Schutter DJG, Honk J. The cerebellum in emotion regulation: a repetitive transcranial magnetic stimulation study. Cerebellum. 2009;8:28–34.
67. Miller TD, Ferguson KJ, Reid LM, Wardlaw JM, Starr JM, Seckl JR, et al. Cerebellar vermis size and cognitive ability in community-dwelling elderly men. Cerebellum. 2013;12:68–73.
68. Cabeza R, Nyberg L. Imaging cognition II: an empirical review of 275 PET and fMRI studies. J Cogn Neurosci. 2000;12:1–47.
69. Ramnani N. The primate cortico-cerebellar system: anatomy and function. Nat Rev Neurosci. 2006;7(7):511–22.
70. Hokkanen LSK, Kauranen V, Roine RO, Salonen O, Kotila M. Subtle cognitive deficits after cerebellar infarcts. Eur J Neurol. 2006;13(2):161–70.
71. Ravizza SM, McCornick CA, Schlerf JE, Justus T, Ivry RB, Fiez JA. Cerebellar damage produces selective deficits in verbal working memory. Brain. 2006;129:306–20.
72. Tadesco AM, Chiricozzi FR, Clausi S, Lupo M, Molinari M, Leggio MG. The cerebellar cognitive profile. Brain. 2011;134(Pt 12):3672–86.
73. Woodruff-Park DS, Vogel RW, Ewers M, Coffey J, Boyko OB, Lemieux SK. MRI-assessed volume of cerebellum correlates with associative learning. Neurobiol Learn Mem. 2001;76(3):342–57.
74. Luft AR, Skalej M, Schulz JB, Welte D, Kolb R, Burk K, et al. Patterns of age-related shrinkage in cerebellum and brainstem observed in vivo using three-dimensional MRI volumetry. Cereb Cortex. 1999;9(7):712–21.
75. Wegiel J, Wisniewski HM, Dziewiatkowski J, Badmajew E, Tarnawski M, Reisberg B, et al. Cerebellar atrophy in Alzheimer’s disease—clinicopathological correlations. Brain Res. 1999;818(1):41–50.
76. Sjobeck M, Englund E. Alzheimer’s disease and the cerebellum: a morphologic study on neuronal and glial changes. Dement Geriatr Cogn Disord. 2001;12(3):211–8.
77. Thomann PA, Schlafer C, Seidl U, Santos VD, Essig M, Schroder J. The cerebellum in mild cognitive impairment and Alzheimer’s disease—a structural MRI study. J Psychiatr Res. 2008;42(14):1198–202.
78. Rombouts SA, van Swieten JC, Pijnenburg YA, Goekoop R, Barkhof F, Scheltens P. Loss of frontal fMRI activation in early frontotemporal dementia compared to early AD. Neurology. 2003;60(12):1904–8.
79. Yoon CW, Seo SW, Park J, Kwak KC, Yoon U, Suh MK, et al. Cerebellar atrophy in patients with subcortical-type vascular cognitive impairment. Cerebellum. 2013;12:35–42.
80. Whitwell JL, Weigand SD, Boeve BF, Senjem ML, Gunter JL, DeJesus-Hernandez M, et al. Neuroimaging signatures of frontotemporal dementia genetics: C9ORF72, tau, progranulin and sporadics. Brain. 2012;135(Pt 3):794–806.
81. Wu T, Hallett M. The cerebellum in Parkinson’s disease. Brain. 2013;136(Pt 3):696–709.
82. Scharmüller W, Ille R, Schienle A. Cerebellar contribution to anger recognition deficits in Huntington’s disease. Cerebellum. 2013;12(6):819–25.
83. Andersen K, Andersen BB, Pakkenberg B. Stereological quantification of the cerebellum in patients with Alzheimer’s disease. Neurobiol Aging. 2012;33(1):197.e111–120.
84. Canu E, McLaren DG, Fitzgerald ME, Bendlin BB, Zoccatelli G, Alessandrini F, et al. Microstructural diffusion changes are independent of macrostructural volume loss in moderate to severe Alzheimer’s disease. J Alzheimers Dis. 2010;19(3):963–76.
85. Moller C, Vrenken H, Jiskoot L, Versteeg A, Barkhof F, Scheltens P, et al. Different patterns of gray matter atrophy in early- and late-onset Alzheimer’s disease. Neurobiol Aging. 2013;34(8):2014–22.
86. Bas O, Acer N, Mas N, Karabekir HS, Kusbeci OY, Sahin B. Stereological evaluation of the volume and volume fraction of intracranial structures in magnetic resonance images of patients with Alzheimer’s disease. Ann Anat Anat Anz Off Organ Anat Ges. 2009;191(2):186–95.
87. Ishii K, Sasaki M, Kitagaki H, Yamaji S, Sakamoto S, Matsuda K, et al. Reduction of cerebellar glucose metabolism in advanced Alzheimer’s disease. J Nucl Med. 1997;38(6):925–8.
88. Vidoni ED, Thomas GP, Honea RA, Loskutova N, Burns JM. Evidence of altered corticomotor system connectivity in early-stage Alzheimer’s disease. J Neurol Phys Ther JNPT. 2012;36(1):8–16.
89. Nocuń A, Wojcza J, Szczepańska-Szerej H, Wilczyński M, Chrapko B. Quantitative evaluation of crossed cerebellar diaschisis, using voxel-based analysis of Tc-99m ECD brain SPECT. Nucl Med Rev Cent East Eur. 2013;16(1):31–4.
90. Sui R, Zhang L. Cerebellar dysfunction may play an important role in vascular dementia. Med Hypotheses. 2012;78(1):162–5. doi:10.1016/j.mehy.2011.10.017.
91. Jacova C, Hsiung GY, Tawankanjanachot I, Dinelle K, McCormick S, Gonzalez M, et al. Anterior brain glucose hypometabolism predates dementia in progranulin mutation carriers. Neurology. 2013;81(15):1322–31.
92. Asokan AG, D’souza S, Jeganathan Pai S. Fahr’s syndrome—an interesting case presentation. J Clin Diagn Res. 2013;7(3):532–3.
93. Calabrò RS, Spadaro L, Marra A, Bramanti P. Fahr’s disease presenting with dementia at onset: a case report and literature review. Behav Neurol. 2014;Article ID 750975, 3 pages. doi:10.1155/2014/75097.
94. Cohen OS, Hoffman C, Lee H, Champman J, Fulbright RK, Prohovnik I. MRI detection of the cerebellar syndrome in Creutzfeldt-Jackob Disease. Cerebellum. 2009;8:373–81.
95. Young GS, Geschwind MD, Fischbein NJ, Martindale JL, Henry RG, Liu S. Diffusion weighted and fluid-attenuated inversion recovery imaging in Creutzfeldt-Jakob disease: high sensitivity and specificity for diagnosis. AJNR Am J Neuroradiol. 2005;26:1551–62.
96. Ferrer I, Puig B, Blanco R, Martí E. Prion protein deposition and abnormal synaptic protein expression in the cerebellum in Creutzfeldt-Jakob disease. Neuroscience. 2000;97(4):715–26.
97. Brown P, Kenney K, Little B, Ironside J, Will R, Cervenáková L. Intracerebral distribution of infectious amyloid protein in spongiform encephalopathy. Ann Neurol. 1995;38:245–53.
98. Tanaka S, Saito M, Morimatsu M, Ohama E. Immunohistochemical studies of the PrP(CJD) deposition in Creutzfeldt-Jakob disease. Neuropathology. 2000;20:124–33.
99. Cooper SA, Murray KL, Heath CA, Will RG, Knight RS. Sporadic Creutzfeldt-Jakob disease with cerebellar ataxia at onset in the UK. J Neurol Neurosurg Psychiatry. 2006;77:1273–5.
100. Ortega-Cuberoa S, Luquína MR, Domínguezb I, Arbizub I, Pagolaa J, Carmona-Abellána MM, et al. Structural and functional neuroimaging in human prion diseases. Neurologia. 2013;28:299–308.
101. Ramos LR, Simoes EJ, Albert MS. Dependence in activities of daily living and cognitive impairment strongly predicted mortality in older urban residents in Brazil: a 2-year follow-up. J Am Geriatr Soc. 2001;49(9):1168–75.
102. Fatemi SH, Aldinger KA, Ashwood P, Bauman ML, Blaha CD, Blatt GJ, et al. Consensus paper: pathological role of the cerebellum in autism. Cerebellum. 2012;11(3):777–807.
103. Stoodley CJ, Schmahmann JD. Evidence for topographic organization in the cerebellum of motor control versus cognitive and affective processing. Cortex. 2010;46:831–44.
104. Skefos J, Cummings C, Enzer K, Holiday J, Weed K, Levy E, et al. Regional alterations in Purkinje cell density in patients with autism. PLoS One. 2014;9:e81255.
105. Fatemi SH, Stary JM, Halt AR, Realmuto GR. Dysregulation of Reelin and Bcl-2 proteins in autistic cerebellum. J Autism Dev Disord. 2001;31:529–35.
106. Gharani N, Benayed R, Mancuso V, Brzustowicz LM, Millonig JH. Association of the homeobox transcription factor, ENGRAILED 2, 3, with autism spectrum disorder. Mol Psychiatry. 2004;9(5):474–84.
107. Kuemerle B, Gulden F, Cherosky N, Williams E, Herrup K. The mouse Engrailed genes: a window into autism. Behav Brain Res. 2007;176(1):121–32.
108. Cheh MA, Millonig JH, Roselli LM, Ming X, Jacobsen E, Kamdar S, et al. En2 knockout mice display neurobehavioral and neurochemical alterations relevant to autism spectrum disorder. Brain Res. 2006;1116(1):166–76.
109. Ieraci A, Forni PE, Ponzetto C. Viable hypomorphic signaling mutant of the Met receptor reveals a role for hepatocyte growth factor in postnatal cerebellar development. Proc Natl Acad Sci. 2002;99(23):15200–5.
110. Sousa I, Clark TG, Toma C, Kobayashi K, Choma M, Holt R, et al. MET and autism susceptibility: family and case–control studies. Eur J Hum Genet. 2009;17(6):749–58.
111. Vargas DL, Nascimbene C, Krishnan C, Zimmerman AW, Pardo CA. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol. 2005;57(1):67–81.
112. Fatemi SH, Folsom TD, Reutiman TJ, Thuras PD. Expression of GABAB receptors is altered in brains of subjects with autism. Cerebellum. 2009;8(1):64–9.
113. Fatemi SH, Reutiman TJ, Folsom TD, Huang H, Oishi K, Mori S, et al. Maternal infection leads to abnormal gene regulation and brain atrophy in mouse offspring: implications for genesis of neurodevelopmental disorders. Schizophr Res. 2008;99(1):56–70.
114. Courchesne E, Webb SJ, Schumann CM. From toddlers to adults: the changing landscape of the brain in autism. In: Amaral D, Geschwind D, Dawson G, editors. Autism spectrum disorders. Oxford: Oxford University Press; 2011. p. 611–31.
115. Stanfield AC, McIntosh AM, Spencer MD, Philip R, Gaur S, Lawrie SM. Towards a neuroanatomy of autism: a systematic review and meta-analysis of structural magnetic resonance imaging studies. Eur Psychiatry. 2008;23(4):289–99.
116. Verly M, Verhoeven J, Zink I, Mantini D, Peeters R, Deprez S, et al. Altered functional connectivity of the language network in ASD: role of classical language areas and cerebellum. NeuroImage Clin. 2014;4:374–82.
117. Catani M, Jones DK, Daly E, Embiricos N, Deeley Q, Pugliese L, et al. Altered cerebellar feedback projections in Asperger syndrome. Neuroimage. 2008;41(4):1184–91.
118. Cleavinger HB, Bigler ED, Johnson JL, Lu J, McMahon W, Lainhart JE. Quantitative magnetic resonance image analysis of the cerebellum in macrocephalic and normocephalic children and adults with autism. J Int Neuropsychol Soc. 2008;14(03):401–13.
119. Pierce K, Courchesne E. Evidence for a cerebellar role in reduced exploration and stereotyped behavior in autism. Biol Psychiatry. 2001;49(8):655–64.
120. Cheung C, Chua SE, Cheung V, Khong PL, Tai KS, Wong TKW, et al. White matter fractional anisotrophy differences and correlates of diagnostic symptoms in autism. J Child Psychol Psychiatry. 2009;50(9):1102–12.
121. Kates WR, Burnette CP, Eliez S, Strunge LA, Kaplan D, Landa R, et al. Neuroanatomic variation in monozygotic twin pairs discordant for the narrow phenotype for autism. Am J Psychiatr. 2004;161(3):539–46.
122. Webb SJ, Sparks BF, Friedman SD, Shaw DW, Giedd J, Dawson G, et al. Cerebellar vermal volumes and behavioral correlates in children with autism spectrum disorder. Psychiatry Res Neuroimaging. 2009;172(1):61–7.
123. Wang P, Erickson CA, Ginsberg G, Rathmell B, Cerubini M, Zarevics P. Of STX209 (arbaclofen) on social and communicative function in ASD: results of an 8 week open label trial. San Diego: International Meeting for Autism Research; 2011.
124. Ji L, Chauhan A, Brown WT, Chauhan V. Increased activities of Na+/K+−ATPase and Ca2+/Mg2+−ATPase in the frontal cortex and cerebellum of autistic individuals. Life Sci. 2009;85:788–93.
125. Anheim M, Tranchant C, Koenig M. The autosomal recessive cerebellar ataxias. N Engl J Med. 2012;366:636–46.
126. Brancati F, Dallapiccola B, Valente EM. Joubert syndrome and related disorders. Orphanet J Rare Dis. 2010;5:20.
127. Poretti A, Huisman TA, Scheer I, Boltshauser E. Joubert syndrome and related disorders: spectrum of neuroimaging findings in 75 patients. AJNR Am J Neuroradiol. 2011;32:1459–63.
128. Wallis LI et al. Proton spectroscopy and imaging at 3 T in ataxia-telangiectasia. AJNR Am J Neuroradiol. 2007;28:79–83.
129. Prodi E, Grisoli M, Panzeri M, Minati LF, Fattori F, Erbetta A, et al. Supratentorial and pontine MRI abnormalities characterize recessive spastic ataxia of Charlevoix-Saguenay. A comprehensive study of an Italian series. Eur J Neurol. 2013;20:138–46.
130. Rafiq M, Sharrack N, Shaw PI, Hadjivassiliou M. A neurological rarity not to be missed: cerebrotendinous xanthomatosis. Pract Neurol. 2011;11:296–300.
131. Della Nave R, Ginestroni A, Tessa C, Salvatore E, Bartolomei I, Salvi F, et al. Brain white matter tracts degeneration in Friedreich ataxia. An in vivo MRI study using tract-based spatial statistics and voxel based morphometry. Neuroimage. 2008;40:19–25.
132. Pagani E, Ginestroni A, Della Nave R, Agosta F, Salvi F, De Michele G, et al. Assessment of brain white matter fibre bundle atrophy in patients with Friedreich’s ataxia. Radiology. 2010;255:882–9.
133. Akhlaghi H, Corben L, Georgiou-Karistianis N, Bradshaw J, Storey E, Delatycki MB, et al. Superior cerebellar peduncle atrophy in Friedreich’s ataxia correlates with disease symptoms. Cerebellum. 2011;10:81–7.
134. Akhlaghi H, Yu J, Corben L, Georgiou-Karistianis N, Bradshaw JL, Storey E, et al. Cognitive deficits in Friedreich ataxia correlate with micro-structural changes in dentatorubral tract. Cerebellum. 2014;13:187–98.
135. Corben LA, Kashuk SR, Akhlaghi H, Jamadar S, Delatycki MB, Fielding J, et al. Myelin paucity of the superior cerebellar peduncle in individuals with Friedreich ataxia: an MRI magnetization transfer imaging study. J Neurol Sci. 2014. doi:10.1016/j.jns.2014.05.057.
136. Gilman S, Junck L, Markel DS, Koeppe RA, Kluin KJ. Cerebral glucose hypermetabolism in Friedreich’s ataxia detected with positron emission tomography. Ann Neurol. 1990;28:750–7.
137. 1H MR spectroscopy in Friedreich’s ataxia and ataxia with oculomotor apraxia type 2. Brain Res. 2010;1358:200–10.
138. De Stefano N, Dotti MT, Mortilla M, Federico A. Magnetic resonance imaging and spectroscopic changes in brain of patients with cerebrotendineous xanthomatosis. Brain. 2001;124:121–31.
139. Walterfang M, Fahey M, Abel L, Fietz M, Wood A, Bowman E, et al. Size and shape of the corpus callosum in adult Niemann–Pick type C reflects state and trait illness variables. AJNR Am J Neuroradiol. 2011;32:1340–6.
140. Walterfang M, Abel LA, Desmond P, Fahey MC, Bowman EA, Velakoulis D. Cerebellar volume correlates with saccadic gain and ataxia in adult Niemann-Pick type C. Mol Genet Metab. 2013;108:85–9.
141. Tedeschi G, Bonavita S, Barton NW, Bertolino A, Frank JA, Patronas NJ, et al. Proton magnetic resonance spectroscopic imaging in the clinical evaluation of patients with Niemann-Pick type C disease. J Neurol Neurosurg Psychiatry. 1998;65:72–9.
142. Brunberg JA, Jacquemont S, Hagerman RJ, Berry-Kravis EM, Grigsby J, Leehey MA, et al. Fragile X premutation carriers: characteristic MR imaging findings of adult male patients with progressive cerebellar and cognitive dysfunction. AJNR Am J Neuroradiol. 2002;23:1757–66.
143. Apartis E, Blancher A, Meissner WG, Guyant-Maréchal L, Maltête D, De Broucker T, et al. FXTAS: new insights and the need for revised diagnostic criteria. Neurology. 2012;79:1898–907.
144. Ginestroni A, Guerrini L, Della Nave R, Tessa C, Cellini E, Dotti MT, et al. Morphometry and 1H- MR spectroscopy of the brainstem and cerebellum in three patients with fragile-X premutation. AJNR Am J Neuroradiol. 2007;28:486–8.
145. Hashimoto R, Javan AK, Tassone F, Hagerman RJ, Rivera SM. A voxel-based morphometry study of grey matter loss in fragile X-associated tremor/ataxia syndrome. Brain. 2011;134:863–78.
146. Scaglione C, Ginestroni A, Vella A, Dotti MT, Della Nave R, Rizzo G, et al. MRI and SPECT of midbrain and striatal degeneration in fragile X-associated tremor/ataxia syndrome. J Neurol. 2008;255:144–6.
147. Parker CC, Evans OB. Metabolic disorders causing childhood ataxia. Semin Pediatr Neurol. 2003;10(3):193–9.
148. Barkovitch AJ. An approach to MRI of metabolic disorders in children. Approche IRM des maladies métaboliques de l’enfant. J Neuroradiol (Paris). 2007;34:75–88.
149. Beitzke D, Simbrunner J, Riccabona M. MRI in paediatric hypoxic-ischemic disease, metabolic disorders and malformations—a review. Eur J Radiol. 2008;68:199–213.
150. Pouwels JW, Vanderver A, Bernard G, Wolf Ni, Dreha-Kulczewksi SF, Deoni SCL, et al. Hypomyelinating leukodsystrophies: translational research progress and prospects. Ann Neurol. 2014.
151. Bricout M, Grévent D, Lebre AS, Rio M, Desguerre I, De Lonlay P, et al. Brain imaging in mitochondrial respiratory chain deficiency: combination of brain MRI features as a useful tool for genotype/phenotype correlations. J Med Genet. 2014;51:429–35.
152. Eichler F, Itoh R, Barker P, Mori S, Garrett ES, van Zijl PC, et al. Proton MR spectroscopic and diffusion tensor brain MR imaging in X-linked adrenoleucodystrophy: initial experience. Radiology. 2002;225(1):245–52.
153. Bianchi MC, Sgandurra G, Tosetti M, Battini R, Cioni G. Brain magnetic resonance in the diagnostic of mitochondrial encephalopathies. Biosci Rep. 2007;27(1–3):69–85.
154. Boddaert N, Romano S, Funalot B, Rio M, Sarzi E, et al. 1H MRS spectroscopy evidence of cerebellar high lactate in mitochondrial respiratory chain deficiency. Mol Genet Metab. 2008;93(1):85–8.
155. Steenweg ME, Vanderver A, Blaser S, Bizzi A, de Koning TJ, et al. Magnetic resonance imaging pattern recognition in hypomyelinating disorders. Brain. 2010;133:2971–82.
156. Ciolli L, Krismer F, Nicoletti F, Wenning GK. An update on the cerebellar subtype of multiple system atrophy. Cerebellum. 2014; in press.
157. Gilman S, Wenning GK, Low PA, Brooks DJ, Mathias CJ, et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology. 2008;71:670–6.
158. D’Abreu A, Cendes F. Neuroimaging of ataxia. Curr Clin Neurol. 2013;44:227–45.
159. Minnerop M, Lûders E, Specht K, Schimke N, Thompson PM, Chou YY, et al. Callosal tissues loss in multiple system atrophy—a one year follow-up study. Mov Disord. 2010;25:2613–20.
160. Matsusue E, Fujii S, Kanasaki Y, Ohama E, Ogawa T. Cerebellar lesions in multiple system atrophy: postmortem MR imaging-pathologic correlations. AJNR Am J Neuroradiol. 2009;30:1725–30.
161. Matsusue E, Fujii S, Kanasaki Y, Sugihara S, Miyata H, Ohama E, et al. Putaminal lesion in multiple system atrophy: postmortem MR-pathological correlations. Neuroradiology. 2008;50:559–67.
162. Specht K, Minnerop M, Müller-Hübenthal J, Klockgether T. Voxel-based analysis of multiple-system atrophy of cerebellar type: complementary results by combining voxel-based morphometry and voxel-based relaxometry. Neuroimage. 2005;25:287–93.
163. Loh KB, Rahmat K, Lim S-Y, Ramli N. A hot cross bun sign from diffusion tensor imaging and tractography perspective. Neurol India. 2011;59:266–9.
164. Yang H, Wang X, Liao W, Zhou G, Li L, Ouyang L. Application of tensor diffusion imaging in multiple system atrophy: the involvement of pontine transverse and longitudinal fibers. Int J Neurosci. 2014; in press.
165. Boesch SM, Wolf C, Seppi K, Felber S, Wenning GK, Schocke M. Differentiation of SCA2 from MSA-C using proton magnetic resonance spectroscopic imaging. J Magn Reson Imaging. 2007;25:564–9.
166. Kimura N, Kumamoto T, Nomura T, Hazama Y, Okazaki T. Evaluation of regional cerebral blood flow in cerebellar variant of multiple system atrophy using FineSRT. Clin Neurol Neurosurg. 2009;111:829–34.
167. Mazere J, Meissner WG, Sibon I, Lamare F, Tison F, Allard M, et al. [(123)I]-IBVM SPRECT imaging of cholinergic systems in multiple systems atrophy: a specific alteration of the ponto-thalamic cholinergic pathways (Ch5-Ch6). NeuroImage Clin. 2013;3:212–7.
168. Schulz JB, Klockgether T, Petersen D, Jauch M, Müller-Schauenburg W, Spieker S, et al. Multiple system atrophy: Natural history, MRI morphology and dopamine receptor imaging with 123IBZM-SPECT. J Neurol Neurosurg Psychiat. 1994;57:1047–56.
169. Hauser T, Luft A, Skalej M, Nägele T, Kircher T, Leube D, et al. Visualization and quantification of disease progression in multiple system atrophy. Mov Dis. 2006;18:85–92.
170. Abele M, Bûrk K, Schölsl, Schwartz S, Besenthal I, Dichgans J, et al. The aetiology of sporadic adult-onset ataxia. Brain. 2002;15:961–8.
171. Burk K, Globas C, Wahl T, Bürhing U, Dietz K, Zuhlke C, et al. MRI-based volumetric differentiation of sporadic cerebellar ataxia. Brain. 2004;127:175–81.